SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 4)
Spectra-Physics, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.01 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
847568 10 2
--------------------------------------------------------------------------------
(CUSIP Number)
Seth H. Hoogasian, Esq.
General Counsel
Thermo Electron Corporation
81 Wyman Street
Waltham, Massachusetts 02454-9046
(781) 622-1000
Copy to:
Neil H. Aronson, Esq.
Mintz, Levin, Cohn, Ferris,
Glovsky and Popeo, P.C.
One Financial Center
Boston, Massachusetts 02111
(617) 542-6000
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
November 6, 2001
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box [ ].
================================================
CUSIP NO. 847568 10 2 13D
================================================
============== =================================================================
1
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY)
Thermo Electron Corporation
04-2209186
-------------- -----------------------------------------------------------------
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) _
(b) x
-------------- -----------------------------------------------------------------
3
SEC USE ONLY
-------------- -----------------------------------------------------------------
4
SOURCE OF FUNDS
WC
-------------- -----------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
-------------- -----------------------------------------------------------------
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
================================================================================
NUMBER OF
7 SOLE VOTING POWER
SHARES
13,333,000
-------------------------------------
BENEFICIALLY
OWNED BY 8 SHARED VOTING POWER
EACH 0
-------------------------------------
9 SOLE DISPOSITIVE POWER
REPORT REPORTING
PERSON 13,333,000
-------------------------------------
10 SHARED DISPOSITIVE POWER
WITH
0
================================================================================
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
13,333,000
------------- ------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
------------- ------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
78.5%
------------- ------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
===============================================================================
Thermo Electron Corporation hereby amends its statement on Schedule 13D
relating to the shares (the "Shares") of common stock, par value $0.01 per
share, of Spectra-Physics, Inc. (the "Issuer") as set forth below.
Item 2. Identity and Background
Item 2 is hereby amended and restated to read as follows:
This Amendment is being filed by Thermo Electron Corporation (the
"Reporting Person"), pursuant to Rule 13d-2, to reflect changes to information
previously reported under Item 4 of Schedule 13D. The Reporting Person holds the
Shares of the Issuer that are the subject of this Amendment directly and through
one or more wholly-owned subsidiaries. As of the date of this Amendment,
13,000,000 Shares were held by Spectra-Physics AB, which is a wholly-owned
subsidiary of the Reporting Person, and 333,000 Shares were held directly by the
Reporting Person.
The Reporting Person develops, manufactures and markets technology-based
instruments, components and systems serving multiple markets, including, without
limitation, life sciences, telecommunications and food, drug and beverage
production. The Reporting Person also develops, manufactures and markets
diagnostic and monitoring products serving the healthcare industry.
The principal business address and principal office address of the
Reporting Person, a Delaware corporation, is 81 Wyman Street, Waltham,
Massachusetts 02454-9046.
Appendix A attached to this Amendment sets forth with respect to each
executive officer and director of the Reporting Person his or her (a) name; (b)
residence or business address; (c) present principal occupation or employment
and the name, principal business and address of any corporation or other
organization in which such employment is conducted; and (d) citizenship. To the
knowledge of the Reporting Person, there is no person who may be deemed to be a
controlling person of the Reporting Person.
During the last five years, neither the Reporting Person nor (to the
knowledge of the Reporting Person) any executive officer or director of the
Reporting Person has been convicted in a criminal proceeding (excluding traffic
violations and similar misdemeanors).
During the last five years, neither the Reporting Person nor (to the
knowledge of the Reporting Person) any executive officer or director of the
Reporting Person has been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction which resulted in a judgement,
decree or final order (i) enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws or (ii)
finding a violation with respect to such laws.
Item 4. Purpose of Transaction
The third, fourth and fifth paragraphs of Item 4 are hereby amended and
restated in their entirety as follows:
On August 21, 2001, the Reporting Person issued a press release stating
that the Reporting Person planned to make a cash tender offer by the end of
September 2001 for any and all of the outstanding Shares of the Issuer held by
minority stockholders at $20 per Share in cash. On September 26, 2001, the
Reporting Person announced that it was reevaluating the offer price of $20 per
share in order to analyze the impact on the Issuer of the worsening economic
conditions associated with the terrorist attacks on September 11, 2001. After
the market closed on November 6, 2001, the Reporting Person announced a revised
offer price of $17.50 per share in cash. The Reporting Person currently owns of
record approximately 78.5% of the outstanding Shares.
The Reporting Person is seeking to receive acceptances from holders of
enough Shares so that, when combined with its current ownership of Shares, the
Reporting Person's ownership reaches at least 90%. If the Reporting Person
achieves this 90% ownership threshold, it will acquire as soon as practicable
after February 22, 2002 all remaining outstanding Shares through a subsequent
short-form merger in Delaware. Stockholders who do not tender their Shares to
the Reporting Person during the tender offer would also receive $17.50 per Share
in cash for their Shares in the short-form merger.
The Reporting Person has caused in the past and intends to continue to
cause a majority of the members of the Issuer's board of directors to consist of
the Reporting Person's designees. From time to time, the Reporting Person has
loaned, and may continue to loan, money to the Issuer in such a manner and in
such amounts as it and the Issuer determine to be appropriate.
Except as set forth in this Item 4, neither the Reporting Person nor, to
the Reporting Person's knowledge, any of the executive officers or directors of
the Reporting Person has any current plans or proposals which relate to or would
result in any of the actions specified in clauses (a) through (j) of Item 4 of
Schedule 13D, although the Reporting Person and such other persons do not rule
out the possibility of effecting or seeking to effect any such actions in the
future.
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, the
Reporting Person certifies that the information set forth in this statement is
true, complete and correct.
THERMO ELECTRON CORPORATION
Date: November 21, 2001 /s/ Kenneth J. Apicerno
---------------------------------------
By: Kenneth J. Apicerno
Its: Treasurer
Appendix A is hereby amended and restated in its entirety as follows:
APPENDIX A
The following individuals are executive officers or directors of Thermo
Electron Corporation ("Thermo Electron"). Unless otherwise noted, all such
individuals are citizens of the United States. Unless otherwise noted, the
business address of each executive officer and director of Thermo Electron is 81
Wyman Street, Waltham, Massachusetts 02454-9046.
Peter O. Crisp: Director, Thermo Electron
Mr. Crisp is the vice chairman of Rockefeller Financial Services, Inc.
Frank Jungers: Director, Thermo Electron
Mr. Jungers is a consultant on business and energy matters. His business
address is 822 N.W. Murray Boulevard, Suite 242, Portland, Oregon 97229.
Jim P. Manzi: Director, Thermo Electron
Mr. Manzi is the managing director of Stonegate Capital, a firm he formed
to manage his investments in technology start-up ventures primarily related to
the Internet.
Robert A. McCabe: Director, Thermo Electron
Mr. McCabe is the Chairman of Pilot Capital Corporation, a firm
specializing in private investment and acquisition services. His business
address is Pilot Capital Corporation, 444 Madison Avenue, Suite 2103, New York,
New York 10022.
Robert W. O'Leary: Director, Thermo Electron
Mr. O'Leary is the Chairman and Chief Executive Officer of The Sagamore
Group, a firm specializing in change management situations with a focus on the
service sector.
Hutham S. Olayan: Director, Thermo Electron
Ms. Olayan is the President and a director of Olayan America Corporation, a
firm engaged in private investments, including real estate and advisory
services. Her business address is Suite 1100, 505 Park Avenue, New York, New
York 10022.
Michael E. Porter: Director, Thermo Electron
Dr. Porter is the Bishop William Lawrence University Professor at the
Harvard Business School, and a leading authority on competitive strategy and
international competitiveness. His business address is Harvard Business School,
Soldiers Field Road, Boston, Massachusetts 02163.
Elaine S. Ullian: Director, Thermo Electron
Ms. Ullian is president and chief executive officer of Boston Medical
Center, a 550-bed academic medical center affiliated with Boston University. Her
business address is Boston Medical Center, Talbot 1, One Boston Medical Center
Plaza, Boston, Massachusetts 02118-2393.
Richard F. Syron: Director, Chairman of the Board and
Chief Executive Officer, Thermo Electron
Marijn E. Dekkers: Director, President and Chief Operating
Officer, Thermo Electron
Mr. Dekkers is a citizen of The Netherlands.
Guy Broadbent: Vice President, Thermo Electron;
President, Optical Technologies
Mr. Broadbent is a citizen of the United Kingdom.
Barry S. Howe: Vice President, Thermo Electron;
President, Measurement and Control
Seth H. Hoogasian: Vice President and General Counsel,
Thermo Electron
Theo Melas-Kyriazi: Vice President and Chief Financial
Officer, Thermo Electron
Mr. Melas-Kyriazi is a citizen of Greece.
Peter E. Hornstra: Corporate Controller and Chief
Accounting Officer, Thermo Electron